Denali Therapeutics (United States)
- Research works
- 106 ▲ 481% vs 2013–17
- Citations
- 3.9k 37.1 per fractional work
- Top-10% rate
- 29.2% record average 16.5%
- Open access
- 64% world 28%
Not ranked overall: Denali Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 8.8×. Every wedge is a field page.
- Neuroscience 8.8×
- Veterinary 7.1×
- Biochemistry, Genetics and Molecular Biology 5.6×
- Immunology and Microbiology 5.3×
- Physics and Astronomy 2.2×
- Medicine 1.6×
- Arts and Humanities 0.8×
- Pharmacology, Toxicology and Pharmaceutics 0.8×
- Business, Management and Accounting 0.7×
- Mathematics 0.6×
- Earth and Planetary Sciences 0.4×
- Engineering 0.3×
- Chemistry 0.2×
- Materials Science 0.2×
- Economics, Econometrics and Finance 0.2×
- Psychology 0.1×
- Decision Sciences 0.1×
- Agricultural and Biological Sciences 0.1×
- Computer Science 0.1×
- Environmental Science 0.1×
- Social Sciences 0.0×
Who are the top researchers at Denali Therapeutics (United States)?
Ranked on the composite score, Mark S. Dennis and Jason C. Dugas lead among researchers whose main affiliation is Denali Therapeutics (United States).
- 1 Mark S. Dennis United States · #314,769 worldwide 138 citations · 17 works
- 2 Jason C. Dugas United States · #1,237,405 worldwide 62 citations · 39 works
Which keywords describe research at Denali Therapeutics (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Neurodegeneration, Oxidative Stress, Parkinson's Disease, Neuroinflammation, Innate Immunity, Cytokines, Brain Development and Enzyme Replacement Therapy.
- Macrophages
- Glycosylation
- Cell Culture
- Vascular Cognitive Impairment
- Cerebral Hypoperfusion
- Genetics
- Neurological Disorders
- Endocytosis
- Apoptosis
- Genetic Risk Factors
- Dopaminergic Neurons
- Amyloid Hypothesis
- Neurodegenerative Diseases
- Synaptic Pruning
- Inflammation
- Microglia
- Enzyme Replacement Therapy
- Cytokines
- Neuroinflammation
- Oxidative Stress
- Neurodegeneration
- Parkinson's Disease
- Innate Immunity
- Brain Development
- Lysosomal Storage Disorders
- Mitochondrial Dysfunction
- Astrocytes
- Cancer
- Diagnostic Criteria
- Tau Pathology
- Endothelial Cells
- a-Synuclein
- Solar Wind
- Membrane Fusion
- Neuroprotective Effects
- Cell Death
- Immune Response
- Gene Therapy
- FUS/TLS
- TDP-43
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Neurodegeneration9▲ 59×8 topics
- Oxidative Stress7▲ 8.9×7 topics
- Parkinson's Disease6▲ 51×7 topics
- Neuroinflammation5▲ 40×3 topics
- Innate Immunity4▲ 25×5 topics
- Cytokines4▲ 25×3 topics
- Brain Development3▲ 40×4 topics
- Enzyme Replacement Therapy3▲ 373×1 topic
- Lysosomal Storage Disorders3▲ 454×1 topic
- Microglia3▲ 61×2 topics
- Mitochondrial Dysfunction3▲ 22×6 topics
- Inflammation3▲ 3.1×16 topics
- Astrocytes3▲ 111×1 topic
- Synaptic Pruning3▲ 111×1 topic
- Cancer3▲ 4.5×11 topics
- Neurodegenerative Diseases3▲ 36×4 topics
- Diagnostic Criteria2▲ 22×2 topics
- Amyloid Hypothesis2▲ 75×1 topic
- Tau Pathology2▲ 75×1 topic
- Dopaminergic Neurons2▲ 63×2 topics
- Endothelial Cells2▲ 172×2 topics
- Genetic Risk Factors2▲ 77×1 topic
- a-Synuclein2▲ 77×1 topic
- Apoptosis2▲ 12×6 topics
- Solar Wind2▲ 40×2 topics
- Endocytosis2▲ 137×1 topic
- Membrane Fusion2▲ 189×1 topic
- Neurological Disorders2▲ 6.1×8 topics
- Neuroprotective Effects2▲ 22×2 topics
- Genetics2▲ 4.9×6 topics
- Cell Death2▲ 13×3 topics
- Cerebral Hypoperfusion2▲ 120×1 topic
- Immune Response2▲ 5.5×5 topics
- Vascular Cognitive Impairment2▲ 120×1 topic
- Gene Therapy1▲ 15×2 topics
- Cell Culture1▲ 24×2 topics
- FUS/TLS1▲ 121×1 topic
- Glycosylation1▲ 25×2 topics
- TDP-431▲ 121×1 topic
- Macrophages1▲ 14×2 topics
Which research topics does Denali Therapeutics (United States) publish most on?
By volume in 2022–2025: Lysosomal Storage Disorders Research, Neuroinflammation and Neurodegeneration Mechanisms, Alzheimer's disease research and treatments and Parkinson's Disease Mechanisms and Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lysosomal Storage Disorders Research Physiology 3 works
- 2 Neuroinflammation and Neurodegeneration Mechanisms Neurology 3 works
- 3 Alzheimer's disease research and treatments Physiology 2 works
- 4 Parkinson's Disease Mechanisms and Treatments Neurology 2 works
- 5 Cellular transport and secretion Cell Biology 2 works
- 6 Neurological Disease Mechanisms and Treatments Neurology 2 works
- 7 Amyotrophic Lateral Sclerosis Research Neurology 1 works
- 8 Calcium signaling and nucleotide metabolism Physiology 1 works
- 9 Ionosphere and magnetosphere dynamics Astronomy and Astrophysics 1 works
- 10 Accounting and Organizational Management Management Information Systems 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Denali Therapeutics (United States)'s research output changed?
Output in 2018–2022 was 481% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in South San Francisco
- Sunesis (United States)
- Exelixis (United States)
- Kaiser Permanente South San Francisco Medical Center
- Cytokinetics (United States)
- Portola Pharmaceuticals (United States)
- NGM Biopharmaceuticals (United States)
- Rapt Therapeutics (United States)
- Atara Biotherapeutics (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.